Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.
about
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancerCost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysisThymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapyContinuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastasesDeaths and major biographical events: a study of all cancer deaths in Germany from 1995 to 2009.The treatment of primary and metastatic hepatic neoplasms using percutaneous cryotherapy.Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS studyNoradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases.Neo-adjuvant therapy improves resectability rates for colorectal liver metastases.A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature.Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.Practice parameters for the management of colonic cancer II: other issues. Recommendations of the Colorectal Surgical Society of Australia.Evolution in the treatment of metastatic colorectal carcinoma of the liverPalliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative GroupHepatic artery chemotherapy in the management of colorectal metastases.A simplified technique of percutaneous hepatic artery port-catheter insertion for the treatment of advanced hepatocellular carcinoma with portal vein invasionReview article: non-systemic chemotherapy in the treatment of colorectal cancer-portal vein, hepatic arterial and intraperitoneal approaches.Quality of life and chronotherapy.Current treatment for liver metastases from colorectal cancer.Palliative treatment of patients with colorectal cancer.Health-related quality of life in colorectal cancer patients.Gastroduodenal ulceration following hepatic arterial chemotherapy: the role of methylene blue endoscopy in the investigation of pain.Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems.What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.Transcatheter intraarterial therapies: rationale and overviewNew developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').Assessing patients' needs and preferences in the management of advanced colorectal cancer.Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials.Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.Embolisation of the right gastric artery in patients undergoing hepatic arterial infusion chemotherapy using two possible approach routesHepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastasesInfluence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma.Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials.EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer.Nitric oxide inhibition sustains vasopressin-induced vasoconstriction.Infusion pumps for systemic and intra-arterial chemotherapy of colorectal liver metastases.Effect of continuous regional vasoactive agent infusion on liver metastasis blood flowMetastatic colorectal cancer-past, progress and future
P2860
Q24240109-B84C9F38-4534-476E-8533-A79DCF2E40C4Q24554238-29C646EA-9199-4524-AD66-43C41C2AC1A6Q24795468-BAEE8CE9-5437-4E95-AA75-4CBA884C9DD0Q28366222-3B6FC60B-0D9E-41B4-921C-E7F085E19014Q30317477-602EB0E4-103A-4061-8DBA-1208A38A56E4Q30477022-AF32A9B2-5650-48F9-8310-3FE0575C1D3DQ30563967-3D8CC6B0-51C5-4E29-A8AC-7C43E9716A06Q30674169-1E472C78-974E-4C34-A6AE-E33A986EE363Q30988365-208E44A9-B6A6-46F8-B02C-DE15896EC46EQ33390290-BA4D2D32-A6FC-4544-96A2-1B64DB3A922EQ33502056-7D477962-314B-4B74-BAE0-3A3D7ED6B7A1Q33649096-B7BE7D99-EC6A-4175-9641-6529AD2AABD7Q33708807-0585EDC5-D082-4A95-8B33-3F3AC91CF2CEQ33868416-6CC7A765-92AE-4BAA-85ED-BA92A40ACFCCQ34021183-63407FC8-339A-48A3-88D5-427CF3E6BD99Q34116771-C57E9643-4C7B-4CFF-9E1E-876129515F28Q34280744-693283B9-4A6B-4E3F-B8F0-74EBF17C1C03Q34374142-A8162296-AC8D-4E37-9834-9AEAF9F31B86Q34606508-E316A622-9C95-405D-8654-6A770483B229Q35047600-13CB65B7-B452-44C7-8B08-AFAB0986321CQ35111182-04640709-E76C-4E2E-9114-37F20A54DA60Q35204956-1C832A46-8253-4BC2-B867-7B9C53CAE6D2Q36065977-A8D9D98C-CE42-4AED-83B4-1A6A2D4BA736Q36067527-5268556E-A336-4DBA-937F-B9C45C070DCCQ36097254-646CAEDA-71BB-490A-B7A3-C5F49E01F85BQ36104314-38ECC69C-4162-4552-9F61-8DF132421E01Q36291281-CE63A36D-69DD-46D2-AD04-78E4C1AE5EF3Q36291291-97047FA3-4E4B-4EBB-8566-7FA737666065Q36291299-3C6EAF91-D503-478E-A312-1A72585EAA04Q36308195-4328CB25-5B07-4870-BF8E-7902200FAC90Q36324688-87D6A216-ED2D-4760-937D-17FD744F17E5Q36409952-DC8E3AF3-59F6-4988-B72C-DB2CCAFB6650Q36431417-CCCB41F5-62ED-4EE9-8EE7-55D7B8F9E53EQ36619301-70673BB4-7E98-4B9F-A205-47259264291CQ36620872-4D48D2D4-B3D1-49AE-9CFD-BB2D05F84048Q36646598-A1967853-252E-4A63-A427-CE2DB48CB9C3Q36702224-E0F0811B-71F7-415A-B28F-A952DBFCBD92Q36821382-2BF2FD6F-4AD8-4EBB-A85A-CA719AAEAE37Q36890438-6F91616A-69BF-4A15-8ED6-C30054984206Q36893806-268F2098-3CEF-413A-A970-66EBAA8C4311
P2860
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Quality of life and survival w ...... r colorectal liver metastases.
@en
Quality of life and survival w ...... r colorectal liver metastases.
@nl
type
label
Quality of life and survival w ...... r colorectal liver metastases.
@en
Quality of life and survival w ...... r colorectal liver metastases.
@nl
prefLabel
Quality of life and survival w ...... r colorectal liver metastases.
@en
Quality of life and survival w ...... r colorectal liver metastases.
@nl
P2093
P1433
P1476
Quality of life and survival w ...... r colorectal liver metastases.
@en
P2093
J Houghton
T G Allen-Mersh
P304
P356
10.1016/S0140-6736(94)90750-1
P407
P577
1994-11-01T00:00:00Z